These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34035258)

  • 1. INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer.
    Rodgers SJ; Ooms LM; Oorschot VMJ; Schittenhelm RB; Nguyen EV; Hamila SA; Rynkiewicz N; Gurung R; Eramo MJ; Sriratana A; Fedele CG; Caramia F; Loi S; Kerr G; Abud HE; Ramm G; Papa A; Ellisdon AM; Daly RJ; McLean CA; Mitchell CA
    Nat Commun; 2021 May; 12(1):3140. PubMed ID: 34035258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
    Reed DE; Shokat KM
    Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A late endosome signaling hub that couples PI3Kα and WNT/β-catenin signaling in breast cancer.
    Rodgers SJ; Hamila SA; Mitchell CA; Ooms LM
    Mol Cell Oncol; 2021; 8(4):1954470. PubMed ID: 34616876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms of class 1A PI3K and Wnt/β-catenin coupled signaling in breast cancer.
    Rodgers SJ; Mitchell CA; Ooms LM
    Biochem Soc Trans; 2023 Aug; 51(4):1459-1472. PubMed ID: 37471270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosome maturation links PI3Kα signaling to lysosome repopulation during basal autophagy.
    Rodgers SJ; Jones EI; Arumugam S; Hamila SA; Danne J; Gurung R; Eramo MJ; Nanayakkara R; Ramm G; McGrath MJ; Mitchell CA
    EMBO J; 2022 Oct; 41(19):e110398. PubMed ID: 35968799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential conversion of PtdIns3P to PtdIns(3,5)P
    Rodgers SJ; Jones EI; Mitchell CA; McGrath MJ
    Autophagy; 2023 Apr; 19(4):1365-1367. PubMed ID: 36103410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib.
    Qu N; Wang G; Su Y; Chen B; Zhou D; Wu Y; Yuan L; Yin M; Liu M; Peng Y; Zhou W
    Biochem Pharmacol; 2024 Aug; 226():116347. PubMed ID: 38852646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
    Gasser JA; Inuzuka H; Lau AW; Wei W; Beroukhim R; Toker A
    Mol Cell; 2014 Nov; 56(4):595-607. PubMed ID: 25458846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.
    Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA
    Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations.
    Park YL; Kim HP; Cho YW; Min DW; Cheon SK; Lim YJ; Song SH; Kim SJ; Han SW; Park KJ; Kim TY
    Int J Cancer; 2019 Jan; 144(2):389-401. PubMed ID: 29978469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
    Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP
    Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
    She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
    BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lipid kinase PIKfyve reveals a role for phosphatase Inpp4b in the regulation of PI(3)P-mediated lysosome dynamics through VPS34 activity.
    Saffi GT; Wang CA; Mangialardi EM; Vacher J; Botelho RJ; Salmena L
    J Biol Chem; 2022 Aug; 298(8):102187. PubMed ID: 35760104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN Regulates PI(3,4)P
    Malek M; Kielkowska A; Chessa T; Anderson KE; Barneda D; Pir P; Nakanishi H; Eguchi S; Koizumi A; Sasaki J; Juvin V; Kiselev VY; Niewczas I; Gray A; Valayer A; Spensberger D; Imbert M; Felisbino S; Habuchi T; Beinke S; Cosulich S; Le Novère N; Sasaki T; Clark J; Hawkins PT; Stephens LR
    Mol Cell; 2017 Nov; 68(3):566-580.e10. PubMed ID: 29056325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer.
    Liu H; Paddock MN; Wang H; Murphy CJ; Geck RC; Navarro AJ; Wulf GM; Elemento O; Haucke V; Cantley LC; Toker A
    Cancer Discov; 2020 Aug; 10(8):1226-1239. PubMed ID: 32513774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
    Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
    J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells.
    Sun Y; Ding H; Liu X; Li X; Li L
    Tumour Biol; 2014 May; 35(5):4469-77. PubMed ID: 24420152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
    Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
    Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα.
    Ding J; Wang X; Zhang Y; Sang X; Yi J; Liu C; Liu Z; Wang M; Zhang N; Xue Y; Shen L; Zhao W; Luo F; Liu P; Cheng H
    Cancer Lett; 2019 Jan; 440-441():54-63. PubMed ID: 30315845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.